DHR - Danaher Corp Stock Price, Fair Value and News

$228.65+2.49 (+1.10%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DHR Price Action

Last 7 days

-2.7%

Last 30 days

-1.9%

Last 90 days

-16.1%

Trailing 12 Months

-0.7%

DHR RSI Chart

DHR Valuation

Market Cap

165.1B

Price/Earnings (Trailing)

42.43

Price/Sales (Trailing)

6.96

EV/EBITDA

31.97

Price/Free Cashflow

33.18

DHR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DHR Fundamentals

DHR Revenue

Revenue (TTM)

23.7B

Rev. Growth (Yr)

3.09%

Rev. Growth (Qtr)

0.96%

DHR Earnings

Earnings (TTM)

3.9B

Earnings Growth (Yr)

-27.55%

Earnings Growth (Qtr)

-9.81%

DHR Profitability

EBT Margin

19.22%

Return on Equity

7.59%

Return on Assets

4.83%

Free Cashflow Yield

3.01%

DHR Investor Care

Buy Backs (1Y)

2.25%

Diluted EPS (TTM)

5.24

DHR Alerts

1 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	23.7B	23.6B	23.7B	0
2023	26.1B	25.4B	24.6B	23.9B
2022	24.5B	23.8B	23.0B	26.6B
2021	24.8B	26.7B	28.1B	24.8B
2020	18.0B	18.9B	20.4B	22.3B
2019	17.2B	17.4B	17.6B	17.9B
2018	18.1B	17.9B	17.5B	17.0B
2017	17.2B	17.4B	17.8B	18.3B
2016	15.2B	16.0B	16.6B	16.9B
2015	17.9B	16.5B	15.3B	14.4B
2014	18.5B	18.7B	19.0B	19.2B
2013	18.2B	18.2B	18.2B	18.3B
2012	17.1B	18.0B	18.0B	18.3B
2011	12.9B	13.4B	14.8B	16.1B
2010	11.2B	11.8B	12.2B	12.6B
2009	0	0	0	10.8B

Get all data in R, Python etc through our Historical Stock Data APIs

About Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

CEO	Mr. Rainer M. Blair
WEBSITE	danaher.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	65535

Danaher Corp Frequently Asked Questions

What is the ticker symbol for Danaher Corp? What does DHR stand for in stocks?

DHR is the stock ticker symbol of Danaher Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Danaher Corp (DHR)?

As of Fri Dec 20 2024, market cap of Danaher Corp is 165.15 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DHR stock?

You can check DHR's fair value in chart for subscribers.

Is Danaher Corp a good stock to buy?

The fair value guage provides a quick view whether DHR is over valued or under valued. Whether Danaher Corp is cheap or expensive depends on the assumptions which impact Danaher Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DHR.

What is Danaher Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, DHR's PE ratio (Price to Earnings) is 42.43 and Price to Sales (PS) ratio is 6.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DHR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Danaher Corp's stock?

In the past 10 years, Danaher Corp has provided 0.146 (multiply by 100 for percentage) rate of return.